This study is in progress, not accepting new patients
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
SARS-CoV-2, mRNA-1273, mRNA-1273 vaccine, SARS-CoV-2 Vaccine, Coronavirus, Virus Diseases, Messenger RNA, COVID-19, COVID-19 Vaccine, Moderna, mRNA-1273.214
- in progress, not accepting new patients
- Start Date
- Completion Date
- ModernaTX, Inc.
- Click here to access the website, http://www.kidcovestudy.com, for additional information for the study, such as Study Overview, Participation, Site Locations, along with contact numbers for each location for the study.
- Phase 2/3 research study
- Study Type
- About 11950 people participating
- Last Updated